LONA
LeonaBio, Inc.$8.68+0.33 (+3.95%)Prev Close$8.35·MCap$24.3M·P/E—·Vol10.9K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
14
$113.3K
◆
Net Activity
Net Seller
$113.3K
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at LeonaBio, Inc. (LONA) has been exclusively selling, with 0 insider purchases totaling $0.00 and 14 insider sales totaling $113.3K. The most recent insider transaction was by CHURCH KEVIN (officer: CHIEF SCIENTIFIC OFFICER), who sold $7.3K worth of shares on Mar 5, 2026. LeonaBio, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $24.3M.
LONA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | Sell | 1,359 | $5.37 | $7.3K | 25,178 |
| Mar 5, 2026 | Litton Mark James | director, officer: PRESIDENT and CEO | Sell | 5,156 | $5.37 | $27.7K | 57,926 |
| Mar 5, 2026 | Renninger Robert | officer: CHIEF FINANCIAL OFFICER | Sell | 906 | $5.37 | $4.9K | 15,851 |
| Mar 5, 2026 | San Martin Javier | officer: CHIEF MEDICAL OFFICER | Sell | 1,720 | $5.37 | $9.2K | 15,887 |
| Mar 5, 2026 | Worthington Mark | officer: GENERAL COUNSEL and CCO | Sell | 1,328 | $5.37 | $7.1K | 18,376 |
| Jan 5, 2026 | Worthington Mark | officer: General Counsel and CCO | Sell | 876 | $6.88 | $6.0K | 13,978 |
| Dec 31, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Sell | 876 | $6.88 | $6.0K | 0 |
| Dec 31, 2025 | Litton Mark James | President and CEO | Sell | 2,586 | $6.88 | $17.8K | 0 |
| Dec 31, 2025 | Renninger Robert | Chief Financial Officer | Sell | 297 | $6.88 | $2.0K | 0 |
| Dec 31, 2025 | San Martin Javier | CHIEF MEDICAL OFFICER | Sell | 1,644 | $6.88 | $11.3K | 0 |
| Jun 30, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Sell | 8,526 | $0.29 | $2.5K | 0 |
| Jun 30, 2025 | Litton Mark James | President and CEO | Sell | 25,123 | $0.29 | $7.4K0.6% OS | 0 |
| Jun 30, 2025 | Renninger Robert | SVP, Finance and Accounting | Sell | 2,897 | $0.29 | $850.27 | 0 |
| Jun 30, 2025 | San Martin Javier | CHIEF MEDICAL OFFICER | Sell | 10,842 | $0.29 | $3.2K | 0 |
| Jan 3, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Sell | 8,510 | $0.56 | $4.8K | 130,761 |
| Jan 3, 2025 | Litton Mark James | President and CEO | Sell | 25,107 | $0.56 | $14.1K0.6% OS | 242,591 |
| Jan 3, 2025 | Renninger Robert | VP of Finance | Sell | 2,881 | $0.56 | $1.6K | 89,724 |
| Jan 3, 2025 | San Martin Javier | CHIEF MEDICAL OFFICER | Sell | 10,826 | $0.56 | $6.1K | 35,841 |
| Jan 3, 2025 | Worthington Mark | General Counsel and CCO | Sell | 8,510 | $0.56 | $4.8K | 83,735 |
| Sep 5, 2024 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Sell | 2,525 | $0.57 | $1.4K | 92,684 |
| Sep 5, 2024 | Gengos Andrew | CFO and Chief Business Officer | Sell | 1,272 | $0.57 | $719.95 | 97,532 |
| Sep 5, 2024 | Lenington Rachel | COO and CDO | Sell | 2,525 | $0.57 | $1.4K | 20,870 |
| Sep 5, 2024 | Litton Mark James | President and CEO | Sell | 5,032 | $0.57 | $2.8K | 159,365 |
| Sep 5, 2024 | Worthington Mark | GENERAL COUNSEL | Sell | 2,525 | $0.57 | $1.4K | 51,927 |
| Jun 25, 2024 | Romano Kelly A | Buy | 42,400 | $2.36 | $100.1K1.1% OS | 80,715+111% | |
| Jan 8, 2024 | CHURCH KEVIN | Chief Scientific Officer | Sell | 2,412 | $2.91 | $7.0K | 80,256 |
| Jan 8, 2024 | Gengos Andrew | See Below | Sell | 1,208 | $2.91 | $3.5K | 83,804 |
| Jan 8, 2024 | Lenington Rachel | Chief Operating Officer | Sell | 2,412 | $2.91 | $7.0K | 13,395 |
| Jan 8, 2024 | Litton Mark James | Chief Executive Officer | Sell | 4,820 | $2.91 | $14.0K | 144,397 |
| Jan 8, 2024 | Worthington Mark | General Counsel | Sell | 2,412 | $2.91 | $7.0K | 34,452 |
| Dec 29, 2023 | PERCEPTIVE ADVISORS LLC | Director | Buy | 605,686 | $2.42 | $1.46M15.4% OS | 5,402,964 |
| Jun 9, 2023 | Gengos Andrew | See Below | Buy | 15,000 | $3.43 | $51.4K | 80,012 |
| Jun 6, 2023 | Gengos Andrew | See Below | Buy | 65,012 | $2.95 | $191.6K1.6% OS | 65,012 |
| Mar 31, 2023 | PICKERING GRANT | Director | Buy | 25,000 | $2.41 | $60.4K0.6% OS | 25,783New Position |
| Mar 30, 2023 | JOHNSON JAMES A | Director | Buy | 5,000 | $2.40 | $12.0K | 5,000 |
| Dec 30, 2022 | MILESON GLENNA | Chief Financial Officer | Buy | 50,000 | $2.85 | $142.3K1.3% OS | 159,930+45% |
| Dec 6, 2022 | Romano Kelly A | Director | Buy | 30,000 | $3.29 | $98.7K0.8% OS | 38,315+361% |
| Nov 17, 2022 | MOEBIUS HANS | Chief Medical Officer | Buy | 5,000 | $3.29 | $16.4K | 65,836 |
| Jul 1, 2022 | PERCEPTIVE ADVISORS LLC | Director | Buy | 1,371,362 | $2.99 | $4.10M34.8% OS | 4,797,278+40% |
| Jun 30, 2022 | MOEBIUS HANS | Chief Medical Officer | Buy | 10,000 | $2.88 | $28.8K | 52,955 |
| Jun 24, 2022 | CHURCH KEVIN | Executive VP, Research | Sell | 2,614 | $2.69 | $7.0K | 57,695 |
| Jun 24, 2022 | Lenington Rachel | Chief Operating Officer | Sell | 4,193 | $2.69 | $11.3K | 5,807-42% |
| Jun 24, 2022 | Litton Mark James | Chief Executive Officer | Sell | 7,960 | $2.69 | $21.4K | 128,555 |
| Jun 24, 2022 | MILESON GLENNA | Chief Financial Officer | Sell | 2,614 | $2.69 | $7.0K | 109,167 |
| Jun 24, 2022 | Worthington Mark | General Counsel | Sell | 2,614 | $2.69 | $7.0K | 19,097 |
| Apr 1, 2022 | Romano Kelly A | Director | Buy | 8,000 | $13.11 | $104.9K | 8,315New Position |
LONA Insider Buying Activity
The following table shows recent insider purchases of LeonaBio, Inc. (LONA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 25, 2024 | Romano Kelly A | Buy | 42,400 | $2.36 | $100.1K1.1% OS | 80,715+111% | |
| Dec 29, 2023 | PERCEPTIVE ADVISORS LLC | Director | Buy | 605,686 | $2.42 | $1.46M15.4% OS | 5,402,964 |
| Jun 9, 2023 | Gengos Andrew | See Below | Buy | 15,000 | $3.43 | $51.4K | 80,012 |
| Jun 6, 2023 | Gengos Andrew | See Below | Buy | 65,012 | $2.95 | $191.6K1.6% OS | 65,012 |
| Mar 31, 2023 | PICKERING GRANT | Director | Buy | 25,000 | $2.41 | $60.4K0.6% OS | 25,783New Position |
| Mar 30, 2023 | JOHNSON JAMES A | Director | Buy | 5,000 | $2.40 | $12.0K | 5,000 |
| Dec 30, 2022 | MILESON GLENNA | Chief Financial Officer | Buy | 50,000 | $2.85 | $142.3K1.3% OS | 159,930+45% |
| Dec 6, 2022 | Romano Kelly A | Director | Buy | 30,000 | $3.29 | $98.7K0.8% OS | 38,315+361% |
| Nov 17, 2022 | MOEBIUS HANS | Chief Medical Officer | Buy | 5,000 | $3.29 | $16.4K | 65,836 |
| Jul 1, 2022 | PERCEPTIVE ADVISORS LLC | Director | Buy | 1,371,362 | $2.99 | $4.10M34.8% OS | 4,797,278+40% |
| Jun 30, 2022 | MOEBIUS HANS | Chief Medical Officer | Buy | 10,000 | $2.88 | $28.8K | 52,955 |
| Apr 1, 2022 | Romano Kelly A | Director | Buy | 8,000 | $13.11 | $104.9K | 8,315New Position |
LONA Insider Selling Activity
The following table shows recent insider sales of LeonaBio, Inc. (LONA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | Sell | 1,359 | $5.37 | $7.3K | 25,178 |
| Mar 5, 2026 | Litton Mark James | director, officer: PRESIDENT and CEO | Sell | 5,156 | $5.37 | $27.7K | 57,926 |
| Mar 5, 2026 | Renninger Robert | officer: CHIEF FINANCIAL OFFICER | Sell | 906 | $5.37 | $4.9K | 15,851 |
| Mar 5, 2026 | San Martin Javier | officer: CHIEF MEDICAL OFFICER | Sell | 1,720 | $5.37 | $9.2K | 15,887 |
| Mar 5, 2026 | Worthington Mark | officer: GENERAL COUNSEL and CCO | Sell | 1,328 | $5.37 | $7.1K | 18,376 |
| Jan 5, 2026 | Worthington Mark | officer: General Counsel and CCO | Sell | 876 | $6.88 | $6.0K | 13,978 |
| Dec 31, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Sell | 876 | $6.88 | $6.0K | 0 |
| Dec 31, 2025 | Litton Mark James | President and CEO | Sell | 2,586 | $6.88 | $17.8K | 0 |
| Dec 31, 2025 | Renninger Robert | Chief Financial Officer | Sell | 297 | $6.88 | $2.0K | 0 |
| Dec 31, 2025 | San Martin Javier | CHIEF MEDICAL OFFICER | Sell | 1,644 | $6.88 | $11.3K | 0 |
| Jun 30, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Sell | 8,526 | $0.29 | $2.5K | 0 |
| Jun 30, 2025 | Litton Mark James | President and CEO | Sell | 25,123 | $0.29 | $7.4K0.6% OS | 0 |
| Jun 30, 2025 | Renninger Robert | SVP, Finance and Accounting | Sell | 2,897 | $0.29 | $850.27 | 0 |
| Jun 30, 2025 | San Martin Javier | CHIEF MEDICAL OFFICER | Sell | 10,842 | $0.29 | $3.2K | 0 |
| Jan 3, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Sell | 8,510 | $0.56 | $4.8K | 130,761 |
| Jan 3, 2025 | Litton Mark James | President and CEO | Sell | 25,107 | $0.56 | $14.1K0.6% OS | 242,591 |
| Jan 3, 2025 | Renninger Robert | VP of Finance | Sell | 2,881 | $0.56 | $1.6K | 89,724 |
| Jan 3, 2025 | San Martin Javier | CHIEF MEDICAL OFFICER | Sell | 10,826 | $0.56 | $6.1K | 35,841 |
| Jan 3, 2025 | Worthington Mark | General Counsel and CCO | Sell | 8,510 | $0.56 | $4.8K | 83,735 |
| Sep 5, 2024 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Sell | 2,525 | $0.57 | $1.4K | 92,684 |
| Sep 5, 2024 | Gengos Andrew | CFO and Chief Business Officer | Sell | 1,272 | $0.57 | $719.95 | 97,532 |
| Sep 5, 2024 | Lenington Rachel | COO and CDO | Sell | 2,525 | $0.57 | $1.4K | 20,870 |
| Sep 5, 2024 | Litton Mark James | President and CEO | Sell | 5,032 | $0.57 | $2.8K | 159,365 |
| Sep 5, 2024 | Worthington Mark | GENERAL COUNSEL | Sell | 2,525 | $0.57 | $1.4K | 51,927 |
| Jan 8, 2024 | CHURCH KEVIN | Chief Scientific Officer | Sell | 2,412 | $2.91 | $7.0K | 80,256 |
| Jan 8, 2024 | Gengos Andrew | See Below | Sell | 1,208 | $2.91 | $3.5K | 83,804 |
| Jan 8, 2024 | Lenington Rachel | Chief Operating Officer | Sell | 2,412 | $2.91 | $7.0K | 13,395 |
| Jan 8, 2024 | Litton Mark James | Chief Executive Officer | Sell | 4,820 | $2.91 | $14.0K | 144,397 |
| Jan 8, 2024 | Worthington Mark | General Counsel | Sell | 2,412 | $2.91 | $7.0K | 34,452 |
| Jun 24, 2022 | CHURCH KEVIN | Executive VP, Research | Sell | 2,614 | $2.69 | $7.0K | 57,695 |
| Jun 24, 2022 | Lenington Rachel | Chief Operating Officer | Sell | 4,193 | $2.69 | $11.3K | 5,807-42% |
| Jun 24, 2022 | Litton Mark James | Chief Executive Officer | Sell | 7,960 | $2.69 | $21.4K | 128,555 |
| Jun 24, 2022 | MILESON GLENNA | Chief Financial Officer | Sell | 2,614 | $2.69 | $7.0K | 109,167 |
| Jun 24, 2022 | Worthington Mark | General Counsel | Sell | 2,614 | $2.69 | $7.0K | 19,097 |
LONA Insiders
Similar Stocks to LONA
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B